Follow
Tanja Kühbacher
Tanja Kühbacher
medius KLINIKEN gemeinnützige GmbH
Verified email at medius-kliniken.de - Homepage
Title
Cited by
Cited by
Year
TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells
P Rosenstiel, M Fantini, K Bräutigam, T Kühbacher, GH Waetzig, ...
Gastroenterology 124 (4), 1001-1009, 2003
5462003
S3-Guideline „Colorectal Cancer “2004/2008
W Schmiegel, C Pox, A Reinacher-Schick, G Adler, W Fleig, UR Fölsch, ...
Z Gastroenterol 46, 1-73, 2008
494*2008
Fungi and inflammatory bowel diseases: alterations of composition and diversity
SJ Ott, T Kühbacher, M Musfeldt, P Rosenstiel, S Hellmig, A Rehman, ...
Scandinavian journal of gastroenterology 43 (7), 831-841, 2008
4652008
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial
CSJ Probert, SD Hearing, S Schreiber, T Kühbacher, S Ghosh, IDR Arnott, ...
Gut 52 (7), 998-1002, 2003
4592003
Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease
SJ Ott, NE El Mokhtari, M Musfeldt, S Hellmig, S Freitag, A Rehman, ...
Circulation 113 (7), 929-937, 2006
4532006
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo …
S Vermeire, S Schreiber, R Petryka, T Kuehbacher, X Hebuterne, ...
The Lancet 389 (10066), 266-275, 2017
4372017
S3-Leitlinie „Kolorektales Karzinom “–Aktualisierung 2008. Ergebnis einer evidenzbasierten Konsensuskonferenz (8.–9. Juni 2007)
W Schmiegel, A Reinacher-Schick, D Arnold, U Graeven, V Heinemann, ...
Z gastroenterol 46 (8), 799-840, 2008
362*2008
S3-Leitlinie „Kolorektales Karzinom “-Ergebnisse evidenzbasierter Konsensuskonferenzen am 6./7. Februar 2004 und am 8./9
W Schmiegel, C Pox, A Reinacher-Schick, G Adler, W Fleig, UR Fölsch, ...
Juni, 2007
362*2007
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104: H4 induced haemolytic uraemic syndrome: case-control study
J Menne, M Nitschke, R Stingele, M Abu-Tair, J Beneke, J Bramstedt, ...
BMJ: British Medical Journal 345, 2012
3402012
Bacterial and fungal microbiota in relation to probiotic therapy (VSL# 3) in pouchitis
T Kuehbacher, SJ Ott, U Helwig, T Mimura, F Rizzello, B Kleessen, ...
Gut 55 (6), 833-841, 2006
3172006
Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease
S Schreiber, P Rosenstiel, J Hampe, S Nikolaus, B Groessner, ...
Gut 51 (3), 379-385, 2002
2412002
Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease
T Kuehbacher, A Rehman, P Lepage, S Hellmig, UR Fölsch, S Schreiber, ...
Journal of medical microbiology 57 (12), 1569-1576, 2008
1912008
Vedolizumab induction therapy for inflammatory bowel disease in clinical practice–a nationwide consecutive German cohort study
DC Baumgart, B Bokemeyer, A Drabik, A Stallmach, S Schreiber, ...
Alimentary pharmacology & therapeutics 43 (10), 1090-1102, 2016
1862016
A comparison of oligonucleotide and cDNA-based microarray systems
N Mah, A Thelin, T Lu, S Nikolaus, T Kühbacher, Y Gurbuz, H Eickhoff, ...
Physiological genomics 16 (3), 361-370, 2004
1802004
Efficacy and safety of etrasimod in a phase 2 randomized trial of patients with ulcerative colitis
WJ Sandborn, L Peyrin-Biroulet, J Zhang, M Chiorean, S Vermeire, ...
Gastroenterology 158 (3), 550-561, 2020
1792020
Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab
S Mascheretti, J Hampe, T Kühbacher, H Herfarth, M Krawczak, ...
The pharmacogenomics journal 2 (2), 127-136, 2002
1792002
Mechanisms in failure of infliximab for Crohn's disease
S Nikolaus, A Raedler, T Kühbacher, N Sfikas, UR Fölsch, S Schreiber
The Lancet 356 (9240), 1475-1479, 2000
1652000
S3-guideline conference" Colorectal Cancer" 2004].
W Schmiegel, C Pox, G Adler, W Fleig, UR Fölsch, P Frühmorgen, ...
Deutsche medizinische Wochenschrift (1946) 130, S5, 2005
156*2005
Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease
H Herfarth, F Obermeier, T Andus, G Rogler, S Nikolaus, T Kuehbacher, ...
The American Journal of Gastroenterology 97 (10), 2688-2690, 2002
1502002
S3 Guidelines for Colorectal Carcinoma
W Schmiegel, C Pox, A Reinacher-Schick, G Adler, D Arnold, W Fleig, ...
Zeitschrift für Gastroenterologie 48 (01), 65-136, 2010
1452010
The system can't perform the operation now. Try again later.
Articles 1–20